GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...

The US Food and Drug Administration (FDA) has approved GSK’s triazaacenaphthylene antibiotic, Blujepa (gepotidacin), for ...

from E. coli cells. We incubated purified LT-IL-2 with RPMI 8226 cells and monitored insertion into the membrane by flow cytometry using a PE-labeled antibody against human IL-2. LT-IL-2 could be ...

Findings from a 2023 randomized controlled trial conducted in healthy university students found that taking bovine colostrum ...

The U.S. Food and Drug Administration (FDA) has approved a new class of antibiotics for treating uncomplicated urinary tract ...

If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in controlling the virus, no treatment can yet completely eradicate HIV once it ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss., ...

Researchers have identified antibodies that could lead to a broadly protective norovirus vaccine and new treatment options.

Download the CBSE Class 12 Biology Sample Paper 2025 curated by experts for last-minute revision. Based on past exams and key ...

Mar. 18, 2025 — Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist the treatment. The answer to this antimicrobial ...